Phase II trial of transcatheter arterial micro-embolization using imipenem/cilastatin sodium for refractory pain from tendinopathy and enthesopathy: Multicenter Study (INSTEP study)
Phase 2
- Conditions
- Chronic pain from tendinopathy and enthesopathy refractory to non-surgical management
- Registration Number
- JPRN-UMIN000024385
- Lead Sponsor
- Miyakojima IGRT clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Surgical candidate 2.Patients with severe infection, rheumatoid arthritis, or mental disorder 3.Patients with uncontrollable diabetic mellitus 4.Pain due to spine pathology 5.Patients with osteonecrosis with magnetic resonance imaging (MRI) 6.Patients without possibility of going to hospital and follow up for 6 months. 7.Patient who was decided not to be appropriate for this trial by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method